MiR-525-5p inhibits diffuse large B cell lymphoma progression via the Myd88/NF-κB signaling pathway 1Department of Hematology, Harbin Medical University Cancer Hospital, Harbin, China 2Department of Clinical Laboratory, Harbin Medical University Cancer Hospital, Harbin, China DOI 10.7717/peerj.16388 Academic Editor Peixin Dong Subject Areas Biochemistry, Cell Biology, Hematology, Oncology Keywords DLBCL, MiR-525-5p, The Myd88/NF-κB pathway, Invasion Copyright © Licence This is an open access...